Relmada Therapeutics to Present Data at the Neuroscience Education Institute Congress
/PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today...
Tim Mccarthy Clinical Research Program Virtual Poster Library Neuroscience Education Institute Relmada Therapeutics Inc Therapeutics Inc
Source: prnewswire.com